STUDY QUESTION: Do young adult survivors of childhood cancer know their fertility status, in the context of their parenthood goals and screening for gonadal functioning?
Introduction
Infertility is a common problem among childhood cancer survivors. Rates may vary, depending on the type of treatment, between 11% and 66%, or up to 90% for survivors who have received a bone marrow transplant (Chemaitilly and Cohen, 2017) . These rates are considerably higher than the 6-12% rate in the general population (CDC, 2015) . Guidelines for childhood cancer survivorship care recommend screening for infertility among 'at-risk' survivors (van Dorp et al., 2016) or upon patient request (COG, 2013) . However, many survivors are unaware of this risk (Kim and Mersereau, 2015) , and little guidance is available to providers on how to address potential infertility across the cancer continuum. As such, both fertility counseling and testing are underutilized in pediatric cancer care (Salih et al., 2015) .
While much fertility-related research has focused on adult-onset cancer patients, studies among childhood cancer survivors, who age into their reproductive years, are scarce and based primarily on small, qualitative studies. This is surprising, since childhood cancer survivors constitute a unique and growing population. Many survivors do not recall fertility-related discussions from the time of diagnosis (Hohmann et al., 2011) . As most adult survivors of childhood cancer want children (Reinmuth et al., 2008; Benedict et al., 2015) , many report regret that (potential) infertility was not addressed at diagnosis (Stein et al., 2014) . Urgency to start treatment and the previous lack of fertility preservation options (which remain limited for younger patients) can be contributing factors. Many long-term survivors are unaware of their fertility status (Green et al., 2003; Kim and Mersereau, 2015; Zebrack et al., 2004) , and infertility can be an unexpected challenge during survivorship, leading to concern/worry (Green et al., 2003; Frederick et al., 2016; Thompson et al., 2012) , distress (Schover, 1999) or relationship problems (Zebrack et al., 2004; Crawshaw and Sloper, 2010; Frederick et al., 2016; Thompson et al., 2012) . Some survivors also incorrectly assume they are infertile and have unplanned pregnancies (Zebrack et al., 2004) .
Given the far-reaching impact of fertility-related challenges, educating survivors and offering testing is important. However, securing and interpreting results of fertility testing can also be difficult: Semen analysis and transvaginal ultrasounds provide the most conclusive/detailed information, but they may be experienced as uncomfortable/invasive. Therefore, endocrine testing (i.e. examining hormones via blood work) may be preferred, but hormone levels offer only tentative results. Nevertheless, they could serve as initial screening tools to help determine whether further, more invasive, testing is needed, while also facilitating fertility-related discussions between providers and survivors.
This study examined whether young adult survivors of childhood cancer know their fertility status, desire becoming parents, and report distress if parenthood goals were unfulfilled. Medical records were reviewed to assess whether providers routinely screened for gonadal functioning.
Materials and Methods
Survivors were eligible if they were between 20 and 40 years old, diagnosed with cancer between ages 5 and 18 years, and ≥5 years postdiagnosis. In 2013-2015, survivors were mailed an invitation to participate in an online survey (in English). Survivors could proceed to the survey after providing online consent. This study was part of a larger project on romantic relationships among 149 childhood cancer survivors (Lehmann et al., 2017) , of whom 105 did not have children (70.5%) and were included in the present analyses (Table I) .
These survivors were asked: 'Do you know whether you might be infertile or are unable to have children?' (I am fertile/I am infertile/I don't know) to assess knowledge of fertility status; 'Is it a goal in your life to have (biological) children?' (yes, but not yet/soon/maybe/no) to assess parenthood goals; and 'On a scale from 0 to 10, how upsetting would it be for you if you were unable to have own children?' (0-10, not at all to extremely) to assess potential fertility-related distress.
Medical records were reviewed for the most recent blood work assessing FSH, LH, anti-Mullerian hormone (AMH), estradiol, inhibin B and/or testosterone.
Statistical analysis
It was tested whether responses to the three questions differed by sociodemographic (age, sex, marital status) and cancer-specific factors (diagnosis, age at diagnosis, time since diagnosis), using χ 2 -, t-or F-tests depending on the outcome; accompanied by effect size calculations for fertility-related distress (Cohen's d). Descriptive statistics were examined for blood hormone levels. All analyses were performed using SPSS, version 21 (NY, USA).
Results

Fertility-related knowledge and goals
The majority of survivors (n = 81, 77.1%) did not know their fertility status, while 12 (11.4%) indicated being infertile, and 12 (11.4%) being fertile. Over 80% (n = 89) wanted biological children. Knowledge of fertility status and parenthood goals were unrelated to sociodemographic (age, sex, marital status) or cancer-specific characteristics (type/age at/time since diagnosis).
Two-thirds of survivors (n = 63) reported distress (score ≥ 6; scale = 0-10) if they were unable to have biological children. Female survivors reported more distress than males, and partnered survivors more than singles if they were unable to have children (Table I) . Age was unrelated to distress in the whole sample.
Leukemia survivors reported higher potential distress if they could not have children than brain tumor survivors (Table I) , but other cancer-specific factors (age at/time since diagnosis) were unrelated to level of distress. Notably, survivors who wanted children reported more distress if unable to have children than those who maybe wanted or did not want children (Table I) .
Endocrine testing
Forty survivors (38.1%) had documented assessments of gonadal functioning. Most recent assessments were at 7.4 years post-diagnosis (range: 1 month-17 years) when survivors were 19.6 years of age (range: 10-30 years). Survivors with endocrine data were younger (24 versus 28 years; t(103) = −3.625, P < 0.001) and closer to diagnosis (12 versus 17 years post-diagnosis; t(103) = −3.819, P < 0.001) than survivors with no records, but did not differ by sex, type or age at diagnosis.
FSH and LH were most commonly recorded (n = 33/40 had both), along with testosterone (n = 17/18 males) and estradiol (n = 16/22 females). No survivor had measurements of AMH (females) or inhibin B (males). Importantly, 33 of 40 survivors with documented hormone levels reported not knowing their fertility status, but it remains unknown whether test results were inconclusive or not discussed with survivors. Interpreting documented hormone levels was impossible during this retrospective chart review, as they were single assessments drawn at varying time points in the menstrual cycle, ages, and without information about Tanner staging or hormonal birth control use.
Discussion
While previous studies examined either knowledge of fertility status or desire to become a parent among childhood cancer survivors, this brief report stressed their intersection. Most adult childhood cancer survivors want to become parents, but do not know their fertility status. Given their increased risk for infertility, several survivors will discover that they are infertile, bearing risk for significant psychological distress. This is also the first study to quantitatively demonstrate that childhood cancer survivors (especially female or partnered survivors) would be distressed about potentially not having children. Finally, this study indicated that screening for gonadal functioning is underutilized by pediatric/survivorship care providers.
Although survivors were of prime reproductive age, fertility-related knowledge was limited. This could be reflected by low rates of endocrine testing, but also the fact that fertility-related discussions are not routine parts of survivorship care, thus limiting awareness among survivors. Screening is currently only recommended for at-risk survivors (van Dorp et al., 2016) , which might explain why only 38% had documented endocrine testing. However, many more survivors could be at risk for infertility as, for example, alkylating agents are used to treat 50% of all childhood cancers along with other gonadotoxic therapies (Mertens et al., 2015) . Another guideline suggests screening for infertility upon survivors' request (COG, 2013), but it remains questionable whether survivors are sufficiently informed to make such requests. It may be argued that it is the providers' responsibility to address all potential late effects (or refer to a reproductive specialist), but guidelines for addressing infertility, the optimal timing of counseling, and appropriate interpretation and communication of test results are needed. Although hormone levels are only suggestive of potential infertility, blood work can be a less invasive first step and enable survivors to make informed decisions regarding further assessment, fertility preservation, timing of family planning or alternatives to biological parenthood. At the same time, other barriers preventing fertility preservation in the pediatric setting need to be addressed, such as cost, families' attitudes/beliefs, provider comfort/communication and appropriate referral systems (Quinn et al., 2008; Klosky et al., 2009) . While the limited sample size and recruitment from a single center may limit the overall generalizability of our findings, this study calls attention to infertility as an under-addressed and ongoing risk for distress among survivors. Female or partnered survivors may be particularly distressed about not having children, but more research is needed on this personal and subjective experience. The lack of fertility-related knowledge and low rates of endocrine testing in our sample highlight the need to further examine how survivors make decisions about fertility testing and how providers should discuss risk and testing. Guidelines and training for providers are needed to routinely address potential infertility in survivorship care.
